Quick Dispatch:
Your summit study tirzepatide Real-world efficacy of tirzepatide in patients with heart failure without diabetes orders ship within 1-2 business days.
Delivery Options:
Order Tracking:
You'll receive a tracking link by email once your summit study tirzepatide Real-world efficacy of tirzepatide in patients with heart failure without diabetes ships.
Need Help?
Questions about summit study tirzepatide Real-world efficacy of tirzepatide in patients with heart failure without diabetes, sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for summit study tirzepatide Real-world efficacy of tirzepatide in patients with heart failure without diabetes in your area.
SUMMIT trial 🫀 Treatment with tirzepatide led to a lower risk of a composite of death from cardiovascular causes or worsening heart failure than placebo and improved health status in patients with
26.88
Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity
24.17
01200-X/asset/429e6fd1-61d1-402a-91a5-b2ec86b1b878/main.assets/gr2_lrg.jpg)
Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial
20.45
Tirzepatide Helps in HFpEF Across Spectrum of Obesity Severity
22.94
SURMOUNT-3 study design This is a phase 3, multicenter, randomized,
27.00
Has Tirzepatide Scaled the HFpEF/Obesity SUMMIT?
21.90
An Observational Study of Cardiovascular Outcomes of Tirzepatide vs Glucagon-Like Peptide-1 Receptor Agonists
20.29
